With apologies for any inconvenience, we are currently experiencing some technical difficulties. Please bear with us.
This bulletin reviews the place in therapy for subcutaneous vedolizumab which may help reduce capacity problems with providers during the current pandemic. A cost calculator tool template is available as a supporting resource.
